Authors
James J.H. Chong
Richard L. Prince
Peter L. Thompson
Sujitha Thavapalachandran
Esther Ooi
Amanda Devine, Edith Cowan UniversityFollow
E E.M. Lim
Elizabeth Byrnes
Germaine Wong
Wai H. Lim
Joshua R. Lewis, Edith Cowan UniversityFollow
Document Type
Journal Article
Publication Title
Journal of the American Heart Association
ISSN
2047-9980
Volume
8
Issue
1
First Page
011028
Last Page
011028
PubMed ID
30595080
Publisher
American Heart Association Inc
School
School of Medical and Health Sciences
RAS ID
28773
Grant Number
NHMRC Number : 1107477
Abstract
Background Neutrophil gelatinase-associated lipocalin ( NGAL ) or lipocalin 2 may promote atherosclerosis and plaque instability leading to increased risk of cardiac events. We investigated the relationships between plasma NGAL , cardiovascular disease biomarkers, and long-term cardiac events. Methods and Results The study population consisted of 1131 ambulant older white women (mean age 75 years) without clinical coronary heart disease ( CHD ) and measures of plasma NGAL in the Perth Longitudinal Study of Ageing Women with 14.5-year CHD and heart failure hospitalizations or death (events) captured using linked records. Over 14.5 years, 256 women had CHD events, while 118 had heart failure events. Per SD increase in log-transformed NGAL there was a 35% to 37% increase in relative hazards for CHD and heart failure events in unadjusted analyses, which remained significant after adjustment for conventional risk factors for CHD events (hazard ratio 1.29, 95% CI 1.13-1.48, P0.05). Women in the highest 2 quartiles of NGAL had higher relative hazards for CHD events compared with women in the lowest quartile hazard ratio 1.61, 95% CI 1.08-2.39, P=0.019 and hazard ratio 1.97, 95% CI 1.33-3.93, P=0.001, respectively. These associations were independent of high-sensitivity cardiac troponin I, homocysteine, and estimated renal function. NGAL correctly reclassified 1 in 4 women who sustained a CHD event up in risk and 1 in 10 women without CHD events down in risk. Conclusions NGAL was associated with increased risk of long-term CHD events, independent of conventional risk factors and biomarkers. These findings provide mechanistic insight into the role of NGAL with cardiac events.
DOI
10.1161/JAHA.118.011028
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License
Comments
Chong, J. J., Prince, R. L., Thompson, P. L., Thavapalachandran, S., Ooi, E., Devine, A., ... & Lewis, J. R. (2019). Association between plasma neutrophil gelatinase-associated lipocalin and cardiac disease hospitalizations and deaths in older women. Journal of the American Heart Association, 8(1), e011028.
Available here.